Financial statements Polaris Laboratories Europe
Balance sheet data of POLARIS LABORATORIES EUROPE
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 4 324 084,40 | 4 196 651,38 | 6 273 471,09 | 6 123 782,87 | 4 800 932,99 |
A. Fixed assets | 367 267,73 | 324 530,49 | 669 639,47 | 541 400,93 | 527 567,64 |
B. Current assets | 3 956 816,67 | 3 872 120,89 | 5 603 831,62 | 5 582 381,94 | 4 273 365,35 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 4 324 084,40 | 4 196 651,38 | 6 273 471,09 | 6 123 782,87 | 4 800 932,99 |
A. Equity | -2 468 322,74 | -1 747 740,96 | -409 029,37 | 691 439,06 | 772 523,67 |
B. Liabilities and provisions for liabilities | 6 792 407,14 | 5 944 392,34 | 6 682 500,46 | 5 432 343,81 | 4 028 409,32 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 6 756 604,17 | 5 905 165,14 | 6 527 334,26 | 5 338 716,28 | 3 853 036,83 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.